DNA Print Genomics Receivables

DNA Print Genomics (DNAG) currently reports a receivables of $1.4M as of September 2007. That compares with $210K in the prior-year period — up 583.8% year over year. Use the charts on this page to explore DNA Print Genomics's receivables history and peer comparisons.

DNA Print Genomics's receivables increased from $210K to $1.4M — a 583.8% year-over-year increase (period ending September 2007). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DNA Print Genomics reported $1.4M in receivables as of September 2007. That compares with $210K in the prior-year period — up 583.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $1.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DNA Print Genomics, and consider following DNAG for alerts when major investors trade the stock.

DNA Print Genomics is classified in the Healthcare sector. On receivables, it currently shows $1.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DNAG with unrelated industries.